Insider · CIK 0001578376

Edwards Peter G

Reports to the SEC for 4 companies · HAZELWOOD, MO

sec.gov

Transactions

Companies

Filings

CIK

0001578376

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-09-08	ELUTELUTIA INC. · Restricted Stock UnitsM Exercise/Conversion	GENERAL COUNSEL	MExercise/Conversion	−4,625 sh	—	—	0
2022-09-08	ELUTELUTIA INC.M Exercise/Conversion	GENERAL COUNSEL	MExercise/Conversion	+4,625 sh	—	—	4,625
2022-09-08	ELUTELUTIA INC.F Tax Payment	GENERAL COUNSEL	FTax Payment	−1,127 sh	$7.30	−$8,227.1	3,498
2022-03-08	ELUTELUTIA INC. · Restricted Stock UnitsA Award	GENERAL COUNSEL	AAward	+4,625 sh	—	—	4,625
2022-03-08	ELUTELUTIA INC. · Stock Option (Right to Buy)A Award	GENERAL COUNSEL	AAward	+31K sh	—	—	31,000
2022-03-08	ELUTELUTIA INC. · Restricted Stock UnitsA Award	GENERAL COUNSEL	AAward	+8,700 sh	—	—	8,700
2021-08-31	ELUTELUTIA INC. · Stock Option (Right to Buy)A Award	GENERAL COUNSEL	AAward	+96.2K sh	—	—	96,200
2018-06-15	CECelanese CorpS Sale	EVP & GC	SSale	−3,674 sh	$115.44	−$424K	12,160
2018-06-15	CECelanese CorpS Sale	EVP & GC	SSale	−3,674 sh	$115.44	−$424K	12,192.685
2018-05-11	CECelanese CorpL Small Acquisition	EVP & GC	LSmall Acquisition	+17.297 sh	$109.05	+$1,886.238	15,866.685
2018-03-05	CECelanese CorpL Small Acquisition	EVP & GC	LSmall Acquisition	+15.388 sh	$103.97	+$1,599.89	15,849.388
2018-01-27	CECelanese CorpF Tax Payment	EVP & GC	FTax Payment	−2,363 sh	$112.16	−$265K	15,834
2017-01-27	CECelanese CorpA Award	EVP & GC	AAward	+18.2K sh	—	—	18,197
2016-06-03	Baxalta IncD Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−216K sh	—	—	0
2016-06-03	Baxalta IncStock Option (Right to Buy)D Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−76.2K sh	—	—	0
2016-03-03	Baxalta IncA Award	SVP and General Counsel	AAward	+33.1K sh	—	—	216,311
2015-07-01	Baxalta IncStock Option (Right to Buy)A Award	SVP and General Counsel	AAward	+76.2K sh	—	—	76,202
2015-07-01	Baxalta IncJ Other	SVP and General Counsel	JOther	+183K sh	—	—	182,540
2015-05-27	Keenova Therapeutics plcM Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	+6,192 sh	$41.73	+$258K	40,035
2015-05-27	Keenova Therapeutics plcM Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	+3,994 sh	$29.89	+$119K	21,287
2015-05-27	Keenova Therapeutics plcM Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	+7,007 sh	$31.12	+$218K	28,294
2015-05-27	Keenova Therapeutics plcM Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	+5,549 sh	$33.67	+$187K	33,843
2015-05-27	Keenova Therapeutics plcM Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	+3,036 sh	$51.35	+$156K	43,071
2015-05-27	Keenova Therapeutics plcS Sale	Sr. VP & General Counsel	SSale	−25.8K sh	$127.90	−$3.3M	17,293
2015-05-27	Keenova Therapeutics plcStock Options (Right to Buy)M Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	−3,994 sh	—	—	0
2015-05-27	Keenova Therapeutics plcShare Options (Right to Buy)M Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	−7,007 sh	—	—	0
2015-05-27	Keenova Therapeutics plcShare Options (Right to Buy)M Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	−5,549 sh	—	—	2,777
2015-05-27	Keenova Therapeutics plcShare Options (Right to Buy)M Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	−6,192 sh	—	—	6,192
2015-05-27	Keenova Therapeutics plcShare Options (Right to Buy)M Exercise/Conversion	Sr. VP & General Counsel	MExercise/Conversion	−3,036 sh	—	—	9,108
2015-01-02	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+15.7K sh	—	—	15,680
2015-01-02	Keenova Therapeutics plcA Award	Sr. VP & General Counsel	AAward	+2,321 sh	—	—	17,488
2015-01-02	Keenova Therapeutics plcF Tax Payment	Sr. VP & General Counsel	FTax Payment	−195 sh	$96.96	−$18.9K	17,293
2014-12-22	Keenova Therapeutics plcS Sale	Sr. VP & General Counsel	SSale	−1,265 sh	$99.69	−$126K	15,167
2014-12-03	Keenova Therapeutics plcF Tax Payment	Sr. VP & General Counsel	FTax Payment	−231 sh	$91.24	−$21.1K	16,432
2014-12-01	Keenova Therapeutics plcF Tax Payment	Sr. VP & General Counsel	FTax Payment	−1,651 sh	$88.22	−$146K	16,663
2014-01-02	Keenova Therapeutics plcA Award	Sr. VP & General Counsel	AAward	+2,010 sh	—	—	18,484
2014-01-02	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+12.1K sh	—	—	12,144
2013-12-03	Keenova Therapeutics plcF Tax Payment	Sr. VP & General Counsel	FTax Payment	−230 sh	$51.54	−$11.9K	16,474
2013-12-03	Keenova Therapeutics plcF Tax Payment	Sr. VP & General Counsel	FTax Payment	−272 sh	$51.54	−$14K	16,178
2013-12-01	Keenova Therapeutics plcF Tax Payment	Sr. VP & General Counsel	FTax Payment	−1,372 sh	$51.96	−$71.3K	16,704
2013-12-01	Keenova Therapeutics plcF Tax Payment	Sr. VP & General Counsel	FTax Payment	−1,626 sh	$51.96	−$84.5K	16,450
2013-11-21	Keenova Therapeutics plcA Award	Sr. VP & General Counsel	AAward	+4,202 sh	—	—	14,704
2013-11-21	Keenova Therapeutics plcA Award	Sr. VP & General Counsel	AAward	+3,372 sh	—	—	18,076
2013-07-01	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+15.6K sh	—	—	15,630
2013-07-01	Keenova Therapeutics plcA Award	Sr. VP & General Counsel	AAward	+5,455 sh	—	—	10,502
2013-06-28	Keenova Therapeutics plcA Award	Sr. VP & General Counsel	AAward	+5,047 sh	—	—	5,047
2013-06-28	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+12.4K sh	—	—	12,384
2013-06-28	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+8,326 sh	—	—	8,326
2013-06-28	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+7,007 sh	—	—	7,007
2013-06-28	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+3,994 sh	—	—	3,994

Recent filings

Accepted (ET)
Sep 124
Edwards Peter G0001415889-22-009540
SEC(opens sec.gov)
Mar 104
Edwards Peter G0001415889-22-002858
SEC(opens sec.gov)
Sep 14
Edwards Peter G0001415889-21-004171
SEC(opens sec.gov)
Jun 194/A
Edwards Peter G0001306830-18-000153
SEC(opens sec.gov)
Jun 154
Edwards Peter G0001306830-18-000151
SEC(opens sec.gov)
Jan 304
Edwards Peter G0001306830-18-000022
SEC(opens sec.gov)
Jan 314
Celanese Corp0001306830-17-000019
SEC(opens sec.gov)
Jun 74
Baxalta Inc0000899243-16-021966
SEC(opens sec.gov)
Mar 74
Baxalta Inc0000899243-16-015430
SEC(opens sec.gov)
Jul 64
Baxalta Inc0000899243-15-000617
SEC(opens sec.gov)
May 294
Mallinckrodt plc0001445064-15-000097
SEC(opens sec.gov)

Companies

Address

C/O MALLINCKRODT PLC 675 JAMES S. MCDONNELL BLVD.

HAZELWOOD, MO, 63042